|
|
|
|
| LEADER |
00000cam a2200000 7i4500 |
| 001 |
0000092150 |
| 005 |
20200311093000.0 |
| 008 |
170601s2015 gw eng |
| 020 |
|
|
|a 9783527336852
|
| 040 |
|
|
|a UniSZA
|e rda
|
| 050 |
0 |
0 |
|a RS420
|b .S83 2015
|
| 060 |
1 |
0 |
|a QV 745
|b .S942 2015
|
| 090 |
0 |
0 |
|a RS420
|b .S83 2015
|
| 245 |
0 |
0 |
|a Successful drug discovery
|c edited by Janos Fischer and David P. Rotella
|
| 264 |
|
1 |
|a Weinheim, Germany :
|b Wiley-VCH
|c 2015
|
| 300 |
|
|
|a xix, 235 pages :
|b illustration(some color) ;
|c 25 cm.
|
| 336 |
|
|
|a text
|2 rdacontent
|
| 337 |
|
|
|a unmediated
|2 rdamedia
|
| 338 |
|
|
|a volume
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index
|
| 505 |
0 |
|
|a 1. Serendipitous target-based drug discoveries -- 2. Drug discoveries and molecular mechanism of action -- 3. Insulin analogs improving the therapy of diabetes -- 4. The discovery of Stendra (Avanafil) for the Treatment of Erectile Dysfunction -- 5. Dapagliflozin, a selective SGLT2 inhibitor for treatment of diabetes -- 6. Elvitegravir, a new HIV-1 integrase inhibitor for antiretroviral therapy -- 7. Discovery of linagliptin for the treatment of type 2 diabetes mellitus -- 8. The discovery of Alimta (Pemetrexed) -- 9. Perampanel: A novel, noncompetitive AMPA receptor antagonist for the treatment of epilepsy -- 10. Discovery and development of telaprevir (Incivek ) a protease inhibitor to treat hepatitis C infection -- 11. Antibody drug conjugates: design and development of trastuzumab emtansine (T-DM1)
|
| 650 |
|
0 |
|a Drug Discovery
|x Methods
|
| 650 |
|
0 |
|a Drugs
|x Design
|
| 650 |
|
0 |
|a Pharmaceutical chemistry
|
| 700 |
1 |
|
|a Fischer, Janos ,
|e editor
|
| 700 |
1 |
|
|a Rotella, David P. ,
|e editor
|
| 999 |
|
|
|a 1000169234
|b Book
|c OPEN SHELF (30 DAYS)
|e Tembila Campus
|